Search results
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 20 hours agoOsimertinib, produced by AstraZeneca under the brand name Tagrisso, significantly extends the time patients live without their cancer worsening, offering the first effective ...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 6 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 11 hours agoThe clinical trial happened in China, meaning that a U.S.-based study will likely be required by the...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 6 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 7 days agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed...
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 6 days agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 2 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
SciTech Development secures additional funding for cancer trials
Clinical Trials Arena via Yahoo Finance· 23 hours agoClinical-stage oncology pharmaceutical company SciTech Development has secured an additional $3.2m...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 14 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...